Today's trade is in a $39B leading provider of software solutions for the global life sciences sector that is on the verge of breaking multi-year highs with an eye towards making a run at all-time highs.
There is an earnings release coming up soon which I think will be the catalyst to get the move underway.
You need to have a subscription to access this content in full.
Log in or subscribe today to unlock new features and receive Member Benefits.
